Stockscreener 앱 받기
134.87
1.15%
-1.57
시간 외 거래:
135.00
0.13
+0.10%
전일 마감가:
$136.44
열려 있는:
$136.19
하루 거래량:
1.70M
Relative Volume:
0.97
시가총액:
$20.61B
수익:
$4.28B
순이익/손실:
$1.26B
주가수익비율:
17.08
EPS:
7.8957
순현금흐름:
$943.00M
1주 성능:
+4.58%
1개월 성능:
+10.57%
6개월 성능:
+53.04%
1년 성능:
-7.89%
1일 변동 폭
$134.13
$137.09
1주일 범위
$126.44
$137.09
52주 변동 폭
$68.70
$153.06
일루미나 Stock (ILMN) Company Profile
명칭
Illumina Inc
전화
(858) 202-4500
주소
5200 ILLUMINA WAY, SAN DIEGO, CA
ILMN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
134.87 | 20.85B | 4.28B | 1.26B | 943.00M | 7.8957 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
일루미나 Stock (ILMN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-12 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | 재확인 | Citigroup | Neutral |
| 2025-02-28 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-02-10 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2025-02-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-11-12 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-10-17 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-08-28 | 업그레이드 | Argus | Hold → Buy |
| 2024-08-16 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-08-14 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-14 | 개시 | Stephens | Overweight |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-12-11 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-11-10 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | 개시 | Bernstein | Underperform |
| 2023-07-05 | 재개 | JP Morgan | Neutral |
| 2023-01-25 | 다운그레이드 | Argus | Buy → Hold |
| 2023-01-05 | 개시 | Scotiabank | Sector Perform |
| 2022-12-12 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-04 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-07-13 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-01-18 | 업그레이드 | Stifel | Hold → Buy |
| 2022-01-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-01-07 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-19 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-03-31 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | 개시 | Barclays | Underweight |
| 2020-12-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-10-13 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-09-22 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-09-21 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-09-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-08-07 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-08-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-24 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-04-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-10-25 | 개시 | Guggenheim | Buy |
모두보기
일루미나 주식(ILMN)의 최신 뉴스
Using genomic testing to deliver hope to families - Illumina
DNA Computing Market - GlobeNewswire Inc.
Your lab’s new best friend for scalable proteomics: Illumina Protein Prep - Illumina
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually - marketscreener.com
Illumina invests in MyOme to advance AI-driven genomic health models By Investing.com - Investing.com India
Illumina (NASDAQ: ILMN) invests in MyOme to launch AI-driven WGS trial in 2026 - Stock Titan
Stifel reiterates Buy rating on Illumina stock, cites multiple growth levers - Investing.com Australia
Leadership Perspectives: Illumina leads the industry in genomic AI - Illumina
Does Surging Genomics Consumables Demand Reshape The Bull Case For Illumina’s Recurring Revenue Engine (ILMN)? - Yahoo Finance
Zacks.com featured highlights include Illumina, Commercial Metals and Newmont - Yahoo Finance
Precision oncology at your community’s doorstep - Illumina
Illumina Inc ILU Stock Analysis and ForecastAI-Driven Market Analysis & Free Lightning Fast Capital Gains - earlytimes.in
Illumina (ILMN): Assessing Valuation After a Quiet Share Price Rebound - Yahoo Finance
Illumina (NASDAQ:ILMN) Upgraded at Zacks Research - MarketBeat
Illumina at the 2025 China International Import Expo (CIIE) - Illumina
Will Illumina Inc. (ILU) stock draw ESG focused funds2025 Top Decliners & Smart Swing Trading Techniques - Newser
How Illumina Inc. (ILU) stock reacts to fiscal policiesPortfolio Risk Report & Weekly Chart Analysis and Trade Guides - Newser
AI in Biotech Market Is Booming Worldwide | NVIDIA, Illumina - openPR.com
Epigenetics Market size to reach $8.63 Billion by 2035 | Key - openPR.com
American Century Companies Inc. Sells 32,763 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina (ILMN) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance
Schroder Investment Management Group Raises Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Will Illumina Inc. (ILU) stock keep high P E multiplesTrade Signal Summary & Safe Capital Allocation Plans - Newser
Can Illumina Inc. (ILU) stock sustain revenue momentumJuly 2025 Setups & Entry Point Confirmation Signals - Newser
Korea Investment CORP Reduces Position in Illumina, Inc. $ILMN - MarketBeat
Why Illumina Inc. (ILU) stock fits value portfoliosOil Prices & Fast Exit/Entry Strategy Plans - Newser
Genetic testing transformed her cancer care—and her family tree - Illumina
Illumina, Inc. $ILMN Stake Lifted by Spyglass Capital Management LLC - MarketBeat
Illumina, Inc.: Financial Data Forecasts Estimates and Expectations | ILMN | US4523271090 - marketscreener.com
Illumina, Inc.: Target Price Consensus and Analysts Recommendations | ILMN | US4523271090 - marketscreener.com
Skandinaviska Enskilda Banken AB publ Buys 6,800 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc.: Revenue and Earnings Analysts Forecasts Revisions | ILMN | US4523271090 - marketscreener.com
State Board of Administration of Florida Retirement System Purchases 2,240 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc.: Dividend historical data and projections - marketscreener.com
Russell Investments Group Ltd. Has $19.79 Million Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
ILMN: Static price chart | Illumina, Inc. | US4523271090 - marketscreener.com
Why global investors buy Illumina Inc. (ILU) stockJuly 2025 Sentiment & Verified Momentum Watchlists - Newser
Illumina Inc. stock underperforms Monday when compared to competitors - MarketWatch
Tumor Transcriptomics Research Report 2025: An $8.71 Billion Market by 2030, Driven by Rising Global Cancer Prevalence and Advancements in Genomic Sequencing Technologies - GlobeNewswire Inc.
Prudential Financial Inc. Cuts Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Stock Position Lifted by JPMorgan Chase & Co. - MarketBeat
Neuberger Berman Group LLC Purchases 31,438 Shares of Illumina, Inc. $ILMN - MarketBeat
Quadrant Capital Group LLC Buys 17,618 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina’s China Setback Leaves A Discounted Genomics Leader - Finimize
Illumina, Inc. $ILMN Shares Purchased by Coldstream Capital Management Inc. - MarketBeat
Illumina, Inc. Stock (ILMN) Opinions on Strategic Growth and Market Expansion - Quiver Quantitative
Gross margin % of Illumina, Inc. – SIX:ILMN.USD - TradingView
Will Illumina Inc. stock outperform international peersTrade Risk Report & Free Fast Entry Momentum Trade Alerts - BỘ NỘI VỤ
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Is Illumina Inc. stock undervalued vs historical averagesTrend Reversal & Fast Moving Trade Plans - BỘ NỘI VỤ
DNA Sequencing Market to Hit US$ 51.31 Billion by 2034 at 14.9% - openPR.com
일루미나 (ILMN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.21%
0.39%
자본화:
|
볼륨(24시간):